Stingray expands in Europe with Paris acquisition
Pan-European radiotherapy leader Stingray Healthcare Group has acquired the Porte de Saint-Cloud Oncology Centre from the American Hospital of Paris. The transaction was executed through Stingray’s French subsidiary, Amethyst, and marks a significant consolidation in the competitive French healthcare market. Located in Boulogne-Billancourt, the acquired facility is a major regional radiotherapy and oncology provider, delivering approximately 42,000 radiotherapy sessions and…
Amethyst Healthcare acquires Portuguese radiotherapy group Júlio Teixeira
Amethyst Healthcare has acquired Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of its strategic expansion in Western Europe and will strengthen the group’s capacity to deliver advanced radiotherapy care in Portugal. Announced on October 6, 2025, the deal represents a significant strategic milestone in Amethyst’s expansion across Western Europe and…